Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Danielle Mahon, Michael-Christopher Keogh, and more

Danielle Mahon and Michael-Christopher Keogh

EpiCypher has appointed Danielle Mahon as director of scientific sales and Michael-Christopher Keogh as director of markets and application development. Mahon previously held positions in sales at Eppendorf, Mettler Toledo, and Thermo Fisher Scientific. Prior to joining EpiCypher, Keogh served as a principal investigator in the department of cell biology at Albert Einstein College of Medicine.

Ardy Arianpour

Celmatix has appointed Ardy Arianpour to its corporate advisory board. Most recently, Arianpour served as chief commercial officer of Pathway Genomics. He has also held senior executive roles at a number of leading personalized medicine companies including Ambry Genetics and the Cogenics division of Clinical Data.

Heiner Dreismann and Charles Woler

NovellusDx has appointed Heiner Dreismann and Charles Woler to its board of directors. Dreismann currently serves on the boards of several public and private healthcare companies. Previously, he held several senior positions with Roche Group, including president and CEO of Roche Molecular Systems and head of global business development for Roche Diagnostics. Woler previously served as CEO of Roche France, CEO of SmithKline Beecham's European pharmaceutical business, CEO of Cadus Pharmaceuticals, CEO of Neruo3d and Endotis Pharma, and recently Biomnis.

For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.